[Coagulation studies in patients after abdominal surgery].

Post-abdominal surgery, liver cirrhosis patients showed severe coagulation issues, leading to high mortality from disseminated intravascular coagulation (DIC). Gabexate Mesilate (GM) showed potential in preventing DIC in these high-risk surgical patients.